The Institute of Cancer Research

35 inventions

Anti-TCP1a [91a (CTA-191)]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide 1 alpha (TCP1a)

0 reviews 6 references 1 supplier

RalGDS KO Mouse

Invented at The Institute of Cancer Research

Antigen/Gene or Protein Targets: RalGDS

0 reviews 2 references 2 suppliers

Anti-KSV CyclinD [94B]

Invented at The Institute of Cancer Research

IHC IF IP WB

Antigen/Gene or Protein Targets: Kaposi’s Sarcoma Virus D-type cyclin

0 reviews 2 references 1 supplier

Anti-TCP1 [84a (CTA-184)]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide 1 (TCP1)

0 reviews 6 references 1 supplier

Anti-Rheb [Rheb 3H6]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: Rheb

0 reviews 2 references 1 supplier

Anti-TCP1 [22b]

Invented at The Institute of Cancer Research

ELISA IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide-1 (TCP1; CCTalpha)

0 reviews 5 references 1 supplier

Anti-Rheb [Rheb 5D5]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: Rheb

0 reviews Add a reference 1 supplier

Anti-TCP1 [23c (CTA-123)]

Invented at The Institute of Cancer Research

IHC IF IP WB

Antigen/Gene or Protein Targets: TCP1 (T-complex polypeptide 1)

0 reviews 7 references 1 supplier

Anti-Melphalan-modified DNA [Amp4/42]

Invented by Dr Michael Tilby at University of Newcastle upon Tyne The Institute of Cancer Research

ELISA IF

Antigen/Gene or Protein Targets: Melphalan

0 reviews 10 references 1 supplier

Anti-Melphalan-modified DNA [MP5/73]

Invented by Dr Michael Tilby at University of Newcastle upon Tyne The Institute of Cancer Research

ELISA IHC

Antigen/Gene or Protein Targets: Melphalan

0 reviews 18 references 1 supplier

Page 1 of 4

Next Last

27 reagents managed

Anti-KSV CyclinD [94B]

Invented at The Institute of Cancer Research

IHC IF IP WB

Antigen/Gene or Protein Targets: Kaposi’s Sarcoma Virus D-type cyclin

0 reviews 2 references 1 supplier

Anti-TCP1 [23c (CTA-123)]

Invented at The Institute of Cancer Research

IHC IF IP WB

Antigen/Gene or Protein Targets: TCP1 (T-complex polypeptide 1)

0 reviews 7 references 1 supplier

Anti-TCP1 [84a (CTA-184)]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide 1 (TCP1)

0 reviews 6 references 1 supplier

Anti-TCP1a [91a (CTA-191)]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide 1 alpha (TCP1a)

0 reviews 6 references 1 supplier

Anti-TCP1 [22b]

Invented at The Institute of Cancer Research

ELISA IP WB

Antigen/Gene or Protein Targets: T-complex polypeptide-1 (TCP1; CCTalpha)

0 reviews 5 references 1 supplier

FLYRD18 Cell Line

Invented by Mary Collins at The Institute of Cancer Research

0 reviews 5 references 1 supplier

Anti-Rheb [Rheb 3H6]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: Rheb

0 reviews 2 references 1 supplier

Anti-Rheb [Rheb 5D5]

Invented at The Institute of Cancer Research

IP WB

Antigen/Gene or Protein Targets: Rheb

0 reviews Add a reference 1 supplier

RalGDS KO Mouse

Invented at The Institute of Cancer Research

Antigen/Gene or Protein Targets: RalGDS

0 reviews 2 references 2 suppliers

FLYA-13 Cell Line

Invented by Mary Collins at The Institute of Cancer Research

0 reviews 4 references 1 supplier

Page 1 of 3

Next Last

13 members

The Institute of Cancer Research

35 inventions

27 reagents managed

13 members

How we use cookies